13F
中

BNTC BENITEC BIOPHARMA INC

2026Q1 · CUSIP 08205P209 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
87
Δ holders QoQ
+15
Breadth percentile
Top 21%
Whale holders
48
Δ whales
+7
Inst. holding value
$345M
New positions
25
Closed positions
10
Price momentum (1Q)
+5.2%
Put / Call
0/0

Breadth history (34 quarters)

2023Q4: Δ+2 · h=14 2024Q1: Δ+0 · h=14 2024Q2: Δ+4 · h=18 2024Q3: Δ+8 · h=26 2024Q4: Δ+5 · h=31 2025Q1: Δ+7 · h=38 2025Q2: Δ+21 · h=59 2025Q3: Δ-3 · h=56 2025Q4: Δ+16 · h=72 2026Q1: Δ+15 · h=87 2023Q4: holders=14 2024Q1: holders=14 2024Q2: holders=18 2024Q3: holders=26 2024Q4: holders=31 2025Q1: holders=38 2025Q2: holders=59 2025Q3: holders=56 2025Q4: holders=72 2026Q1: holders=87 -21 -10.5 +0 +10.5 +21 125292 23Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 15% +3.5% -16.8%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.93
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2021-09-30: EPS -0.09 2021-12-31: EPS -0.08 2022-03-31: EPS -0.06 2024-12-31: EPS -0.26 2025-03-31: EPS -0.38 2025-06-30: EPS -0.21 2025-09-30: EPS -0.22 2025-12-31: EPS -0.26 2026-03-31: EPS -0.24 -0.42 -0.21 0.00 20212022202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)